CLSH underperformed the S&P500 by 4.37%. CLS Holdings USA, Inc. focuses on the extraction and conversion of cannabinoids in the United States.

Read More

CLSH underperformed by 4.37% the S&P 500. CLS Holdings USA, Inc. focuses on the extraction and conversion of cannabinoids in the United States.

Read More

Titan Fighting Championship 53 was supposed to be headlined by a flyweight championship bout between Juan Puerta and Gastavo Balart, but …

Read More

“Cannabinoids may increase serotonin levels in certain conditions and reduce them in others.” Serotonin is one of the neurotransmitters, or chemical …

Read More

While the FDA hasn’t approved marijuana for treating any health problems, it did approve three cannabinoids as drugs for the treatment of seizures, …

Read More

12, 2017, the National Academy of Science released a 468-page study titled, “The Health Effects of Cannabis and Cannabinoids : The Current State of …

Read More

CBD, a cannabinoid that is associated with medicinal use, does not produce a psychedelic effect. Below is an excerpt from the new budget addressing …

Read More

One, for example, has to do with how the density of a specific cannabinoid receptor, CB1R, decreases with frequent cannabis use. It’s a theory that …

Read More

Brands like OLO isolate the dozen-plus main active ingredients in cannabis, called cannabinoids , and re-blend them in precise ratios. As little as 2 …

Read More

CLS Holdings USA, Inc. focuses on the extraction and conversion of cannabinoids in the United States. The company has market cap of $49.07 million …

Read More